Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities

Author:

Walker Meghan J.12ORCID,Blackmore Kristina M.1,Chang Amy1,Lambert-Côté Laurence3ORCID,Turgeon Annie3ORCID,Antoniou Antonis C.4,Bell Kathleen A.1,Broeders Mireille J. M.5ORCID,Brooks Jennifer D.2ORCID,Carver Tim4,Chiquette Jocelyne36,Després Philippe7ORCID,Easton Douglas F.4,Eisen Andrea18,Eloy Laurence9,Evans D. Gareth10ORCID,Fienberg Samantha1,Joly Yann11,Kim Raymond H.112ORCID,Kim Shana J.2ORCID,Knoppers Bartha M.11ORCID,Lofters Aisha K.213,Nabi Hermann31415,Paquette Jean-Sébastien6ORCID,Pashayan Nora416,Sheppard Amanda J.12,Stockley Tracy L.1718ORCID,Dorval Michel31519ORCID,Simard Jacques320ORCID,Chiarelli Anna M.12

Affiliation:

1. Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada

2. Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada

3. CHU de Québec-Université Laval Research Center, Queébec City, QC G1V 4G2, Canada

4. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK

5. Department for Health Evidence, Radboud University Medical Center, 6525EP Nijmegen, The Netherlands

6. Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval, Québec City, QC G1V 0A6, Canada

7. Department of Physics, Engineering Physics and Optics, Faculty of Science and Engineering, Université Laval, Quebec City, QC G1V 0A6, Canada

8. Sunnybrook Health Science Center, Toronto, ON M4N 3M5, Canada

9. Québec Cancer Program, Ministère de la Santé et des Services Sociaux, Quebec City, QC G1S 2M1, Canada

10. Division of Evolution Infection and Genomic Sciences, The University of Manchester, Manchester M13 9PL, UK

11. Centre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada

12. Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada

13. Women’s College Research Institute, Toronto, ON M5G 1N8, Canada

14. Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada

15. Université Laval Cancer Research Center, Quebec City, QC G1R 3S3, Canada

16. Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London WC1E 6BT, UK

17. Division of Clinical Laboratory Genetics, University Health Network, Toronto, ON M5G 2C4, Canada

18. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada

19. Faculty of Pharmacy, Université Laval, Quebec City, QC G1V 0A6, Canada

20. Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1V 4G2, Canada

Abstract

Risk-stratified breast screening has been proposed as a strategy to overcome the limitations of age-based screening. A prospective cohort study was undertaken within the PERSPECTIVE I&I project, which will generate the first Canadian evidence on multifactorial breast cancer risk assessment in the population setting to inform the implementation of risk-stratified screening. Recruited females aged 40–69 unaffected by breast cancer, with a previous mammogram, underwent multifactorial breast cancer risk assessment. The adoption of multifactorial risk assessment, the effectiveness of methods for collecting risk factor information and the costs of risk assessment were examined. Associations between participant characteristics and study sites, as well as data collection methods, were assessed using logistic regression; all p-values are two-sided. Of the 4246 participants recruited, 88.4% completed a risk assessment, with 79.8%, 15.7% and 4.4% estimated at average, higher than average and high risk, respectively. The total per-participant cost for risk assessment was CAD 315. Participants who chose to provide risk factor information on paper/telephone (27.2%) vs. online were more likely to be older (p = 0.021), not born in Canada (p = 0.043), visible minorities (p = 0.01) and have a lower attained education (p < 0.0001) and perceived fair/poor health (p < 0.001). The 34.4% of participants requiring risk factor verification for missing/unusual values were more likely to be visible minorities (p = 0.009) and have a lower attained education (p ≤ 0.006). This study demonstrates the feasibility of risk assessment for risk-stratified screening at the population level. Implementation should incorporate an equity lens to ensure cancer-screening disparities are not widened.

Funder

Genome Canada

the Canadian Institutes for Health Research

the Québec Ministry of Economy, Science and Innovation through Génome Québec

the Québec Breast Cancer Foundation

the CHU de Québec Foundation

the CHU de Québec–Université Laval Research Center

Cancer Research UK

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3